Stevanato Group S.p.A. (STVN): Price and Financial Metrics
GET POWR RATINGS... FREE!
STVN Stock Price Chart Interactive Chart >
STVN Price/Volume Stats
| Current price | $15.90 | 52-week high | $29.18 |
| Prev. close | $15.68 | 52-week low | $13.35 |
| Day low | $15.11 | Volume | 147,100 |
| Day high | $15.93 | Avg. volume | 327,646 |
| 50-day MA | $15.88 | Dividend yield | N/A |
| 200-day MA | $19.79 | Market Cap | 4.70B |
Stevanato Group S.p.A. (STVN) Company Bio
Stevanato Group S.p.A. engages in the design, production, and distribution of products and systems to provide integrated solutions for pharma and healthcare. Its principal products are linked to containment solutions, drug delivery systems, medical devices, diagnostic, analytical services, visual inspection machines, assembling and packaging machines, and glass forming machine. Stevanato Group S.p.A. was founded in 1949 and is based in Piombino Dese, Italy.
Latest STVN News From Around the Web
Below are the latest news stories about Stevanato Group SpA that investors may wish to consider to help them evaluate STVN as an investment opportunity.
Stevanato Group to Report Fourth Quarter Financial Results on March 8, 2022PIOMBINO DESE, Italy--(BUSINESS WIRE)--Q4 & YE 2021 Earnings notification |
Stevanato Group Appoints Riccardo Butta as President, AmericasPIOMBINO DESE, Italy, February 02, 2022--Stevanato Group, a global provider of drug containment, drug delivery and diagnostic solutions to the pharmaceutical, biotechnology and life sciences industries, today announced the appointment of Riccardo Butta to the role of President, Americas. |
First Bank & Trust Buys Daktronics Inc, Amgen Inc, Bristol-Myers Squibb Co, Sells Pfizer ...Investment company First Bank & Trust (Current Portfolio) buys Daktronics Inc, Amgen Inc, Bristol-Myers Squibb Co, Realty Income Corp, British American Tobacco PLC, sells Pfizer Inc, Canadian Imperial Bank of Commerce, Cisco Systems Inc, , Electronic Arts Inc during the 3-months ended 2021Q4, according to the most recent filings of the investment company, First Bank & Trust. |
Stevanato Group Extends Pen Injector Technology Licensing Agreement With HaselmeierPIOMBINO DESE, Italy, January 26, 2022--Stevanato Group, a global provider of drug containment, drug delivery and diagnostic solutions to the pharmaceutical, biotechnology and life sciences industries, has signed an extension to its licensing agreement with Haselmeier, a company of the medmix group, for its Axis-D™ pen injector technology. |
Is Stevanato Group (STVN) A Smart Long-Term Buy?ClearBridge Investments, an investment management firm, published its “SMID Cap Growth Strategy” third quarter 2021 investor letter – a copy of which can be downloaded here. During the third quarter, the ClearBridge SMID Cap Growth Strategy outperformed the benchmark Russell 2500 Growth Index. On an absolute basis, the Strategy had gains across five of the […] |
STVN Price Returns
| 1-mo | N/A |
| 3-mo | -20.97% |
| 6-mo | -29.18% |
| 1-year | N/A |
| 3-year | N/A |
| 5-year | N/A |
| YTD | -29.18% |
| 2021 | N/A |
| 2020 | N/A |
| 2019 | N/A |
| 2018 | N/A |
| 2017 | N/A |
Loading social stream, please wait...